Candel Therapeutics Inc
NASDAQ:CADL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Candel Therapeutics Inc
NASDAQ:CADL
|
US |
|
B
|
Babcock International Group PLC
XBER:BW3
|
UK |
|
S
|
Sagility India Ltd
NSE:SAGILITY
|
IN |
|
S
|
Stellus Capital Investment Corp
F:GO0
|
US |
|
U
|
Ubiquiti Inc
F:3UB
|
US |
|
A
|
Armstrong World Industries Inc
XBER:91A
|
US |
|
O
|
OFS Capital Corp
F:9UD
|
US |
|
Bank Rakyat Indonesia (Persero) Tbk PT
F:BYR
|
ID |
|
C
|
CDL Hospitality Trusts
SGX:J85
|
SG |
|
T
|
TopBuild Corp
F:28T
|
US |
|
CME Group Inc
NASDAQ:CME
|
US |
|
T
|
Target Corp
XMUN:DYH
|
US |
|
Kikkoman Corp
OTC:KIKOF
|
JP |
|
Abbott Laboratories
NYSE:ABT
|
US |
|
U
|
Ubiquiti Inc
LSE:0LI9
|
US |
Shareholder Yield
Current shareholder yield for CADL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CADL Price
Candel Therapeutics Inc
| Average Annual Return | 109.58% |
| Standard Deviation of Annual Returns | 276.26% |
| Max Drawdown | -94% |
| Market Capitalization | 694.6m USD |
| Shares Outstanding | 73 270 000 |
| Percentage of Shares Shorted | 28.68% |
